• Explore /
  • Videos & Slides
  • / A phase II trial of intravesical chemoimmunotherapy with gemcitabine and bacillus Calmette-Guérin (BCG) for patients with BCG-exposed, high-grade, non-muscle–invasive bladder cancer.

A phase II trial of intravesical chemoimmunotherapy with gemcitabine and bacillus Calmette-Guérin (BCG) for patients with BCG-exposed, high-grade, non-muscle–invasive bladder cancer.

Abstract Video & Slides Poster

Presenter

null

Christopher Gaffney, MD

Memorial Sloan Kettering Cancer Center

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Videos & Slides Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04179162

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr TPS579)

DOI

10.1200/JCO.2023.41.6_suppl.TPS579

Abstract #

TPS579

Poster Bd #

P2

Abstract Disclosures

Similar Videos & Slides

Speaker: Joaquim Bellmunt, MD, PhD

Videos & Slides

2015 Genitourinary Cancers Symposium

Medical Oncologist

Medical Oncologist

Speaker: Joseph W. Kim, MD

Speaker: Andre Rashad Kydd, MD, PhD

Speaker: John Ebben, MD, PhD